Prevention and management of bleeding complications after thrombolysis

This publication has 19 references indexed in Scilit:

• Streptokinase induced defibrination assessed by thrombin time: effects on residual coronary stenosis and left ventricular ejection fraction
  Heart, 1992
• The Risk of Stroke in Patients with Acute Myocardial Infarction after Thrombolytic and Antithrombotic Treatment
  New England Journal of Medicine, 1992
• ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction
  Published by Elsevier ,1992
• Intracranial hemorrhage in association with thrombolytic therapy: Incidence and clinical predictive factors
  Journal of the American College of Cardiology, 1992
• Platelets and Thrombolytic Therapy
  New England Journal of Medicine, 1990
• Correlation between template bleeding times and spontaneous bleeding during treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator.
  Circulation, 1989
• Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
  New England Journal of Medicine, 1989
• The impact of coronary thrombolysis on myocardial infarction
  Fibrinolysis, 1989
• Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
  Journal of the American College of Cardiology, 1988
• RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1985